Could BMS' immuno-oncology hit Opdivo also attack HIV? - FierceBiotech

FierceBiotech

Could BMS' immuno-oncology hit Opdivo also attack HIV? FierceBiotech Researchers in France are investigating whether Opdivo, a checkpoint inhibitor approved to fight some cancers, might also work in HIV. Share Facebook Twitter LinkedIn Email Print. When doctors in Paris treated an HIV-infected lung cancer patient with ... Case Study: Cancer Drug Delivers Shock HIV ImprovementDaily Beast Bristol-Myers Squibb takes Opdivo to China's FDA after lung cancer survival winFiercePharma all 8 news articles »

from Health - Google News http://ift.tt/2i5E9Xw